We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CTNM market cap is 419.55M. The company's latest EPS is USD 0.8832 and P/E is 18.53.
| Quarter End | |
|---|---|
| USD (US$) | |
| Total Revenue | |
| Operating Income | |
| Net Income |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 50M |
| Operating Income | 16.08M |
| Net Income | 22.72M |
| Quarter End | |
|---|---|
| USD (US$) | |
| Total Assets | |
| Total Liabilities | |
| Total Equity |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 130.39M |
| Total Liabilities | 5.7M |
| Total Equity | -67.94M |
| Market Cap | 419.55M |
| Price to Earnings Ratio | 18.53 |
| Price to Sales Ratio | 8.42 |
| Price to Cash Ratio | 27.12 |
| Price to Book Ratio | 3.38 |
| Dividend Yield | - |
| Shares Outstanding | 25.72M |
| Average Volume (1 week) | 48.7k |
| Average Volume (1 Month) | 42.17k |
| 52 Week Change | 12.48% |
| 52 Week High | 16.4622 |
| 52 Week Low | 13.27 |
| Spread (Intraday) | 2.78 (15.9%) |
| Company Name | Contineum Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.contineum-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
